Asset Details
Do you wish to reserve the book?
Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19
Do you wish to request the book?
Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19
2021
Overview
BackgroundGastrointestinal symptoms are common in patients with COVID-19, but prevalence of co-infection with enteric pathogens is unknown.AimsThis study assessed the prevalence of enteric infections among hospitalized patients with COVID-19.MethodsWe evaluated 4973 hospitalized patients ≥ 18 years of age tested for COVID-19 from March 11 through April 28, 2020, at two academic hospitals. The primary exposure was a positive COVID-19 test. The primary outcome was detection of a gastrointestinal pathogen by PCR stool testing.ResultsAmong 4973 hospitalized individuals, 311 were tested for gastrointestinal infections (204 COVID-19 positive, 107 COVID-19 negative). Patients with COVID-19 were less likely to test positive compared to patients without COVID-19 (10% vs 22%, p < 0.01). This trend was driven by lower rates of non-C.difficile infections (11% vs 22% in COVID-19 positive vs. negative, respectively, p = 0.04), but not C. difficile infection (5.1% vs. 8.2%, p = 0.33). On multivariable analysis, infection with COVID-19 remained significantly associated with lower odds of concurrent GI infection (aOR 0.49, 95% CI 0.24–0.97), again driven by reduced non-C.difficile infection. Testing for both C.difficile and non-C.difficile enteric infection decreased dramatically during the pandemic.ConclusionsPathogens aside from C.difficile do not appear to be a significant contributor to diarrhea in COVID-19 positive patients.
Publisher
Springer Nature B.V
Subject
